Home > Financial Ratios > SHUKRA PHARMACEUTICALS

SHUKRA PHARMACEUTICALS
Core EBITDA Margin

    Back to All Ratios
AD     Remove this Ad

SHUKRA PHARMACEUTICALS Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) 39.0626.029.1214.0912.90

What is the latest Core EBITDA Margin ratio of SHUKRA PHARMACEUTICALS ?

The latest Core EBITDA Margin ratio of SHUKRA PHARMACEUTICALS is 39.06 based on Mar2025 Standalone results.
Year Core EBITDA Margin
Mar202539.06
Mar202426.02
Mar20239.12
Mar202214.09
Mar202112.90

How is Core EBITDA Margin of SHUKRA PHARMACEUTICALS Trending?

Years Core EBITDA Margin % Change
Mar2025 39.06
50.12
Mar2024 26.02
185.31
Mar2023 9.12
-35.27
Mar2022 14.09
9.22
Mar2021 12.9 -

Other Financial Ratios of SHUKRA PHARMACEUTICALS


Compare Core EBITDA Margin ratio of peers of SHUKRA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS ₹1,739.8 Cr -7.1% -33% 76.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,341.0 Cr -1.8% -6.4% -10.7% Stock Analytics
DIVIS LABORATORIES ₹160,401.0 Cr -0.3% -5.5% 8.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,175.0 Cr -0.1% 4% 18.7% Stock Analytics
CIPLA ₹107,100.0 Cr 1% -12.3% -5.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,715.9 Cr -4.6% -7% 1.8% Stock Analytics


SHUKRA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS

-7.1%

-33%

76.9%

SENSEX

-1%

-4.7%

6%


You may also like the below Video Courses